AcouSort (OM:ACOU) - Stock Price, News & Analysis

ACOU Stock Overview

A technology company, develops products and solutions for automated preparation of biological samples based on acoustofluidics technology for researchers and life science companies. More details

ACOU fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	2/6
Past Performance	0/6
Financial Health	4/6
Dividends	0/6

Rewards

Revenue is forecast to grow 56.36% per year

Risk Analysis

Makes less than USD$1m in revenue (SEK8M)

Has less than 1 year of cash runway

Earnings have declined by 16.1% per year over past 5 years

Does not have a meaningful market cap (SEK170M)

+ 2 more risks

AcouSort AB (publ) Competitors

Biovica International

OM:BIOVIC B

SEK 162.6m

SenzaGen

OM:SENZA

SEK 206.5m

Intervacc

OM:IVACC

SEK 192.4m

Saniona

OM:SANION

SEK 314.4m

Price History & Performance

Summary of all time highs, changes and price drops for AcouSort
Historical stock prices
Current Share Price	SEK 11.40
52 Week High	SEK 20.80
52 Week Low	SEK 9.32
Beta	0.69
11 Month Change	-12.31%
3 Month Change	-33.53%
1 Year Change	-22.18%
33 Year Change	-58.99%
5 Year Change	14.00%
Change since IPO	31.03%

Recent updates

Shareholder Returns

	ACOU	SE Biotechs	SE Market
7D	-10.6%	-5.8%	-2.1%
1Y	-22.2%	14.3%	10.8%

Return vs Industry: ACOU underperformed the Swedish Biotechs industry which returned 14.3% over the past year.

Return vs Market: ACOU underperformed the Swedish Market which returned 10.8% over the past year.

Price Volatility

Is ACOU's price volatile compared to industry and market?
ACOU volatility
ACOU Average Weekly Movement	9.6%
Biotechs Industry Average Movement	9.3%
Market Average Movement	5.6%
10% most volatile stocks in SE Market	11.2%
10% least volatile stocks in SE Market	3.3%

Stable Share Price: ACOU's share price has been volatile over the past 3 months compared to the Swedish market.

Volatility Over Time: ACOU's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of Swedish stocks.

About the Company

Founded	Employees	CEO	Website
2010	17	Torsten Freltoft	www.acousort.com

AcouSort AB (publ), a technology company, develops products and solutions for automated preparation of biological samples based on acoustofluidics technology for researchers and life science companies. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an integrated blood plasma separation module that enables in-line analysis of blood plasma from whole blood samples; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy.

AcouSort AB (publ) Fundamentals Summary

How do AcouSort's earnings and revenue compare to its market cap?
ACOU fundamental statistics
Market cap	SEK 170.25m
Earnings (TTM)	-SEK 19.30m
Revenue (TTM)	SEK 8.31m

20.5x

P/S Ratio

-8.8x

P/E Ratio

Is ACOU overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ACOU income statement (TTM)
Revenue	SEK 8.31m
Cost of Revenue	SEK 1.05m
Gross Profit	SEK 7.26m
Other Expenses	SEK 26.56m
Earnings	-SEK 19.30m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

Nov 27, 2024

Earnings per share (EPS)	-1.29
Gross Margin	87.41%
Net Profit Margin	-232.27%
Debt/Equity Ratio	0%

How did ACOU perform over the long term?

See historical performance and comparison

ACOU Stock Overview

Rewards

Risk Analysis

AcouSort AB (publ) Competitors

OM:BIOVIC B

SEK 162.6m

OM:SENZA

SEK 206.5m

OM:IVACC

SEK 192.4m

OM:SANION

SEK 314.4m

Price History & Performance

Recent News & Updates

Second quarter 2024 earnings released: kr0.32 loss per share (vs kr0.24 loss in 2Q 2023)

First quarter 2024 earnings released: kr0.25 loss per share (vs kr0.23 loss in 1Q 2023)

AcouSort AB (publ) to Present Two Posters Highlighting the Value of Acoustofluidics Sample Preparation

Full year 2023 earnings released: kr1.29 loss per share (vs kr1.04 loss in FY 2022)

New minor risk - Share price stability

Founder & Independent Director recently bought kr52k worth of stock

Recent updates

Second quarter 2024 earnings released: kr0.32 loss per share (vs kr0.24 loss in 2Q 2023)

First quarter 2024 earnings released: kr0.25 loss per share (vs kr0.23 loss in 1Q 2023)

AcouSort AB (publ) to Present Two Posters Highlighting the Value of Acoustofluidics Sample Preparation

Full year 2023 earnings released: kr1.29 loss per share (vs kr1.04 loss in FY 2022)

New minor risk - Share price stability

Founder & Independent Director recently bought kr52k worth of stock

AcouSort AB (publ) to Report Q3, 2024 Results on Nov 27, 2024

New minor risk - Shareholder dilution

AcouSort AB (publ) has completed a Composite Units Offering.

Third quarter 2023 earnings released: kr0.33 loss per share (vs kr0.32 loss in 3Q 2022)

New major risk - Share price stability

AcouSort AB (publ) to Report Q4, 2023 Results on Feb 28, 2024

New major risk - Financial position

New minor risk - Share price stability

AcouSort (STO:ACOU) Is In A Good Position To Deliver On Growth Plans

AcouSort AB (publ) Recruits Henrik Johansson to the Position as Director of Research and Technology

First quarter 2023 earnings released: kr0.23 loss per share (vs kr0.20 loss in 1Q 2022)

AcouSort AB (publ) Launches Next Generation AcouTrap at CYTO 2023

Full year 2022 earnings released: kr0.98 loss per share (vs kr0.92 loss in FY 2021)

Founder & Independent Director recently bought kr68k worth of stock

Will AcouSort (STO:ACOU) Spend Its Cash Wisely?

Third quarter 2022 earnings released: kr0.32 loss per share (vs kr0.30 loss in 3Q 2021)

Second quarter 2022 earnings released: kr0.31 loss per share (vs kr0.31 loss in 2Q 2021)

The European Innovation Council Awards the Acousort Project Acousome SEK 26 Million to Develop Technology for Exosome-Based Diagnostics

AcouSort AB Announces Executive Appointments

We Think AcouSort (STO:ACOU) Can Afford To Drive Business Growth

AcouSort AB (publ) and Werfen's Joint Patent Application Has Received National Approval in US

AcouSort AB (publ) Announces Scientific Progress with AcouWash Enables New Method for Cancer Treatment Monitoring

First quarter 2022 earnings released: kr0.20 loss per share (vs kr0.15 loss in 1Q 2021)

Founder & Independent Director recently bought kr95k worth of stock

We're Hopeful That AcouSort (STO:ACOU) Will Use Its Cash Wisely

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

AcouSort AB (publ) to Report Fiscal Year 2021 Results on Apr 13, 2022

Third quarter 2021 earnings: Revenues and EPS in line with analyst expectations

AcouSort will launch AcouWash 2 at international conference

Second quarter 2021 earnings released: kr0.31 loss per share (vs kr0.12 loss in 2Q 2020)

AcouSort AB (publ) Announces Development Process of AcouPlasma Optical Reaches Important Milestone

First quarter 2021 earnings released: kr0.15 loss per share (vs kr0.10 loss in 1Q 2020)

We're Not Very Worried About AcouSort's (STO:ACOU) Cash Burn Rate

Acousort Strengthens Commercial Offering with the Release of New Acouwash Application Notes

Full year 2020 earnings released: kr0.70 loss per share (vs kr0.96 loss in FY 2019)

AcouSort AB (publ) to Report Fiscal Year 2020 Results on Apr 14, 2021

AcouSort AB (publ) to Report Q3, 2021 Results on Nov 24, 2021

AcouSort AB Enters Collaboration Agreement with Belgian Diagnostics Company

We Think AcouSort (STO:ACOU) Can Afford To Drive Business Growth

Physio-Tech Co.,Ltd. acquired AcouTrap system from AcouSort AB (publ) (OM:ACOU).

New 90-day high: kr26.90

New 90-day high: kr22.30

New 90-day high: kr21.80

Third quarter 2020 earnings released: kr0.20 loss per share

New 90-day high: kr19.25

New 90-day high: kr16.85

New 90-day high: kr12.40

Shareholder Returns

Price Volatility

About the Company

AcouSort AB (publ) Fundamentals Summary

20.5x

-8.8x